2009 IR News

11.10.2009 Revision of Financial Forecast

11.10.2009 Santen Announces Financial Result for the Second Quarter ended September 30, 2009

08.04.2009 Santen Announces Financial Result for the First Quarter ended June 30, 2009

07.03.2009 Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)

06.24.2009 Notice on the Allotment of Stock Options (Stock Acquisition Rights)

05.12.2009 Santen to Issue Stock Acquisition Rights to the Directors for the Purpose of Granting Stock Options

05.12.2009 Santen to Issue Stock Acquisition Rights to the Corporate Officers for the Purpose of Granting Stock Options

05.12.2009 Santen Announces Financial Results for the Year ended March 31, 2009

04.15.2009 Santen and Merck & Co., Inc Sign Licensing Agreement for Tafluprost, Treatment for Glaucoma and Ocular Hypertension